Erlotinib Directly Inhibits HER2 Kinase Activation and Downstream Signaling Events in Intact Cells Lacking Epidermal Growth Factor Receptor Expression
Cancer Research - United States
doi 10.1158/0008-5472.can-06-3493
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2007
Authors
Publisher
American Association for Cancer Research (AACR)